Marco Laub

Marco Laub

Auto-generated profile, based on publicly available information

Marco Laub

MRC Laboratory of Molecular Biology, Cambridge, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2023 in Science
Verified
Journal Article
Open access
PRPablo Rodríguez-Silvestre
Pablo Rodríguez-Silvestre
MLMarco Laub
Marco Laub
PKPatrycja A. Krawczyk
Patrycja A. Krawczyk
ADAlexandra K. Davies
Alexandra K. Davies
JSJulia P. Schessner
Julia P. Schessner
PKPatrycja Kozik
Patrycja Kozik
During initiation of antiviral and antitumor T cell–mediated immune responses, dendritic cells (DCs) cross-present exogenous antigens on major histocompatibility complex (MHC) class I molecules. Cross-presentation relies on the unusual “leakiness” of endocytic compartments in DCs, whereby internalized proteins escape into the cytosol for proteasome-mediated generation of MHC I–binding peptides. Given that type 1 conventional DCs excel at cross-presentation, we searched for cell type–specific effectors of endocytic escape. We devised an assay suitable for genetic screening and identified a pore-forming protein, perforin-2 ( Mpeg1 ), as a dedicated effector exclusive to cross-presenting cells. Perforin-2 was recruited to antigen-containing compartments, where it underwent maturation, releasing its pore-forming domain. Mpeg1 −/− mice failed to efficiently prime CD8 + T cells to cell-associated antigens, revealing an important role for perforin-2 in cytosolic entry of antigens during cross-presentation.